Christoph Schmid
Arzt,
Facharzt
Hat mitgewirkt an:
-
Immunomodulation of blasts in AML-patients (pts) with clinically approved response modifiers to improve anti leukaemic T-cell reactivity: an ex vivo simulation of the clinical situation
-
Dendritic/antigen presenting cell mediated provision of T-cell receptor gamma delta (TCRγδ) expressing cells contributes to improving antileukemic reactions ex vivo
-
Graft-versus-leukemia effect following hematopoietic stem cell transplantation for leukemia
-
In vivo induction of leukemia-specific adaptive and innate immune cells by treatment of aml-diseased rats and therapy-refractory AML patients with blast modulating response modifiers